Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 682,468 |
|
|||||
| News | (1) | ||||||
| Day High | 399.68 | Low High |
|||||
| Day Low | 393.49 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.22 | -0.06% | 397.48 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 393.52 | 393.49 | 399.68 | 397.48 | 397.70 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,543 | 682,468 | US$ 397.32 | US$ 271,154,780 | - | 316.43 - 448.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:01:51 | 2 | US$ 397.42 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 102.67B | 258.31M | - | 9.92B | 3.57B | 13.82 | 28.76 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 394.72 | 406.86 | 391.25 | 399.31 | 1,079,829 | 2.76 | 0.70% |
| 1 Month | 420.43 | 421.45 | 391.01 | 400.88 | 956,952 | -22.95 | -5.46% |
| 3 Months | 430.00 | 437.00 | 391.01 | 414.16 | 1,137,494 | -32.52 | -7.56% |
| 6 Months | 362.03 | 448.40 | 341.90 | 401.48 | 1,327,519 | 35.45 | 9.79% |
| 1 Year | 326.50 | 448.40 | 316.43 | 376.31 | 1,236,357 | 70.98 | 21.74% |
| 3 Years | 217.74 | 448.40 | 176.36 | 281.26 | 1,508,382 | 179.74 | 82.55% |
| 5 Years | 173.98 | 448.40 | 164.07 | 258.45 | 1,543,286 | 223.50 | 128.46% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
